Research

We fund secondary (metastatic) breast cancer research that improves the lives of people living with the disease today. 100% of donations given specifically for research go directly towards funding research projects.

The average life expectancy of a secondary breast cancer patient once diagnosed is between two and three years. Around 25% will survive for 5 years or more after they are diagnosed.[1] 

To date we've committed £671,000 of funding to research focused on near-time patient benefit. We're determined to continue build a research programme that amplifies our community voice and helps people live longer, better lives alongside secondary breast cancer.

In these pages you will find out about our research progress so far, current projects underway and how we fund research. 

Clinical Trials 

Evidence tells us that clinical research and clinical trials can improve the outcomes of men and women living with secondary breast cancer, through early access to innovative new treatments.

If you are interested in finding out more about clinical trials, our experienced nurse Mel can answer questions, search for trials based on your eligibility, and support you in discussing them with your clinician. 

Find out about Clinical Trials

[1] Cancer Research UK www.cancerresearchuk.org/about-cancer/breast-cancer/survival Accessed: May 2023